Comparison of the Efficacy of the Azithromycin and in Combination with Moxifloxacin on Chlamydial Cervicitis

Phase 3

Recruiting

• Conditions: Chlamydial Cervicitis.; Chlamydial infection of genitourinary tract, unspecified

• Registration Number: IRCT20100130003226N16
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 29 January 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 120

Inclusion Criteria

Women aged 18-35
Having just one partner in the last two months
Married and sexually active
Clinical diagnosis of chlamydial cervicitis and confirmation of diagnosis by Real-Time PCR (in the etiological diagnostic group of PCR)
Syndrome diagnosis of chlamydial cervicitis includes diagnosis based on a set of symptoms that can be found during the history and examination of the patient (in the diagnostic syndromic group)

Exclusion Criteria

Concomitant use of drugs that interfere with azithromycin or moxifluxacin
Having a history of allergy to Quinolones or Macrolides
Use of intrauterine device
pregnancy and pregnancy intent in the next 3 months
lactation
participating in other studies and drug use over the past 4 weeks
abnormal uterine bleeding

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Status of patient's complaints includes vaginal discharge, abdominal pain, painful intercourse. Timepoint: One month and three month after treatment. Method of measurement: Complaint checklist.;Status of clinical findings includes swollen and fragile cervix, and mucopurulent secretions. Timepoint: One month and three month after treatment. Method of measurement: Clinical findings check list.;Lab results. Timepoint: One month and three month after treatment. Method of measurement: Nucleic Acid Amplification Test (Polymerase Chain Reaction).